
HealthMore in Health→
Asthma Study Identifies CBX7 as a New Inflammation Driver
Key Takeaways
- Researchers identified CBX7 as a newly recognized driver of allergic asthma inflammation.
- The protein appears to act both in the cytoplasm and nucleus to sustain cytokine production.
- Reducing CBX7 activity lowered inflammatory cytokine output in immune cells.
- The findings point to a possible future therapeutic target, but not an immediate treatment.
DE
DT Editorial Team··via medicalxpress.com